Insider · CIK 0001237401
David C Hastings
Files at SCYX (SCYNEXIS INC), ABUS (Arbutus Biopharma Corp). First filing Feb 5, 2025, latest Feb 5, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ABUS: Arbutus Biopharma Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Arbutus Biopharma Corp | $73k 22,183 shares | -12% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2025 | SCYX SCYNEXIS INC | AGrant or award Common Stock | +23,000 | $0.00 | $0 | 69,183 | Jun 30, 2025 |
| Jun 26, 2025 | SCYX SCYNEXIS INC | AGrant or award Stock Optionderivative | +23,000 | $0.00 | $0 | 23,000 | Jun 30, 2025 |
| Feb 14, 2025 | ABUS Arbutus Biopharma Corp | AGrant or award Common Shares | +90,100 | $0.00 | $0 | 249,824 | Feb 19, 2025 |
| Feb 14, 2025 | ABUS Arbutus Biopharma Corp | AGrant or award Stock Option (Right to Buy)derivative | +365,800 | $0.00 | $0 | 365,800 | Feb 19, 2025 |
| Feb 4, 2025 | ABUS Arbutus Biopharma Corp | SOpen-market sale Common Shares10b5-1 | -22,183 | $3.28 | $73k | 159,724 | Feb 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.